Stopping second-generation TKIs in CML

Blood. 2017 Feb 16;129(7):805-806. doi: 10.1182/blood-2016-12-757302.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
  • Protein Kinase Inhibitors*

Substances

  • Protein Kinase Inhibitors